Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	MAP kinase activity	MAPK15 MAPK1 MAPK3	8.41e-05	16	109	3	GO:0004707
GeneOntologyMolecularFunction	inositol 1,4,5-trisphosphate-gated calcium channel activity	ITPR1 ITPR2	8.83e-05	3	109	2	GO:0005220
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZNF536 ZBTB2 ZNF584 ZFP30 ZNF280C ZNF275 REST ZNF692 ZNF490 ZSCAN20 SALL1 ZNF780A ZNF648 ZNF81 NR1H4 ZFP62 ZNF574	4.03e-04	1244	109	17	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF536 ZBTB2 ZNF584 ZFP30 ZNF280C ZNF275 REST ZNF692 ZNF490 ZSCAN20 SALL1 ZNF780A ZNF648 ZNF81 NR1H4 ZFP62 ZNF574	5.15e-04	1271	109	17	GO:0000987
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF536 ZBTB2 ZNF584 ZFP30 ZNF280C ZNF275 REST ZNF692 ZNF490 ZSCAN20 SALL1 ZNF780A ZNF648 ZBTB10 ZNF81 NR1H4 ZFP62 ZNF574	6.13e-04	1412	109	18	GO:0000981
GeneOntologyMolecularFunction	calcium channel activity	CALHM1 CALHM3 ITPR1 ITPR2 CNGA2	7.11e-04	129	109	5	GO:0005262
GeneOntologyMolecularFunction	intracellularly ligand-gated monoatomic ion channel activity	ITPR1 ITPR2 CNGA2	7.66e-04	33	109	3	GO:0005217
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF536 ZBTB2 ZNF584 ZFP30 ZNF280C ZNF275 REST ZNF692 ZNF490 ZSCAN20 SALL1 ZNF780A ZNF648 ZBTB10 ZNF81 NR1H4 ZFP62 ZNF574	8.97e-04	1459	109	18	GO:0000977
GeneOntologyMolecularFunction	ligand-gated monoatomic cation channel activity	CALHM1 ITPR1 ITPR2 SCNN1G CNGA2	1.03e-03	140	109	5	GO:0099094
GeneOntologyCellularComponent	ESCRT-0 complex	STAM2 STAM	7.76e-05	3	107	2	GO:0033565
Domain	ZINC_FINGER_C2H2_2	ZNF536 ZBTB2 ZNF584 ZFP30 ZNF280C ZNF275 REST ZNF692 ZNF490 ZNF462 ZNF800 ZSCAN20 SALL1 ZNF780A ZNF648 ZBTB10 ZNF81 ZFP62 ZNF574	9.03e-08	775	108	19	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF536 ZBTB2 ZNF584 ZFP30 ZNF280C ZNF275 REST ZNF692 ZNF490 ZNF462 ZNF800 ZSCAN20 SALL1 ZNF780A ZNF648 ZBTB10 ZNF81 ZFP62 ZNF574	9.40e-08	777	108	19	PS00028
Domain	Znf_C2H2	ZNF536 ZBTB2 ZNF584 ZFP30 ZNF280C ZNF275 REST ZNF692 ZNF490 ZNF462 ZNF800 ZSCAN20 SALL1 ZNF780A ZNF648 ZBTB10 ZNF81 ZFP62 ZNF574	1.63e-07	805	108	19	IPR007087
Domain	ZnF_C2H2	ZNF536 ZBTB2 ZNF584 ZFP30 ZNF280C ZNF275 REST ZNF692 ZNF490 ZNF462 ZNF800 ZSCAN20 SALL1 ZNF780A ZNF648 ZBTB10 ZNF81 ZFP62 ZNF574	1.72e-07	808	108	19	SM00355
Domain	-	ZNF536 ZBTB2 ZNF584 ZFP30 REST ZNF692 ZNF490 ZNF462 ZNF800 ZSCAN20 SALL1 ZNF780A ZNF648 ZBTB10 ZNF81 ZFP62 ZNF574	3.49e-07	679	108	17	3.30.160.60
Domain	zf-C2H2	ZNF536 ZBTB2 ZNF584 ZFP30 ZNF275 REST ZNF692 ZNF490 ZNF462 ZSCAN20 SALL1 ZNF780A ZNF648 ZBTB10 ZNF81 ZFP62 ZNF574	4.64e-07	693	108	17	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF536 ZBTB2 ZNF584 ZFP30 REST ZNF692 ZNF490 ZNF462 ZNF800 ZSCAN20 SALL1 ZNF780A ZNF648 ZBTB10 ZNF81 ZFP62 ZNF574	4.73e-07	694	108	17	IPR013087
Domain	Znf_C2H2-like	ZNF536 ZBTB2 ZNF584 ZFP30 ZNF280C REST ZNF692 ZNF490 ZNF462 ZNF800 ZSCAN20 SALL1 ZNF780A ZNF648 ZBTB10 ZNF81 ZFP62 ZNF574	6.71e-07	796	108	18	IPR015880
Domain	FAM26	CALHM1 CALHM3 CALHM4	3.71e-06	6	108	3	IPR029569
Domain	Ca_hom_mod	CALHM1 CALHM3 CALHM4	3.71e-06	6	108	3	PF14798
Domain	MAPK_ERK1/2	MAPK1 MAPK3	3.31e-05	2	108	2	IPR008349
Domain	ARPC1	ARPC1A ARPC1B	3.31e-05	2	108	2	IPR017383
Domain	MAP_kinase_CS	MAPK15 MAPK1 MAPK3	3.98e-05	12	108	3	IPR003527
Domain	MAPK	MAPK15 MAPK1 MAPK3	3.98e-05	12	108	3	PS01351
Domain	InsP3_rcpt-bd	ITPR1 ITPR2	9.90e-05	3	108	2	IPR000493
Domain	RDM	RFPL4AL1 RFPL4A	3.28e-04	5	108	2	PF11002
Domain	RDM_domain_RFPL	RFPL4AL1 RFPL4A	3.28e-04	5	108	2	IPR022723
Domain	RIH_assoc	ITPR1 ITPR2	4.89e-04	6	108	2	PF08454
Domain	RIH_assoc-dom	ITPR1 ITPR2	4.89e-04	6	108	2	IPR013662
Domain	RIH_dom	ITPR1 ITPR2	4.89e-04	6	108	2	IPR000699
Domain	Ins145_P3_rcpt	ITPR1 ITPR2	4.89e-04	6	108	2	IPR014821
Domain	Ryanodine_recept-rel	ITPR1 ITPR2	4.89e-04	6	108	2	IPR015925
Domain	-	ITPR1 ITPR2	4.89e-04	6	108	2	1.25.10.30
Domain	RYDR_ITPR	ITPR1 ITPR2	4.89e-04	6	108	2	PF01365
Domain	Ins145_P3_rec	ITPR1 ITPR2	4.89e-04	6	108	2	PF08709
Domain	Znf_MYM	ZMYM1 ZMYM3	6.83e-04	7	108	2	IPR010507
Domain	zf-FCS	ZMYM1 ZMYM3	6.83e-04	7	108	2	PF06467
Domain	TRASH_dom	ZMYM1 ZMYM3	9.07e-04	8	108	2	IPR011017
Domain	TRASH	ZMYM1 ZMYM3	9.07e-04	8	108	2	SM00746
Domain	VHS	STAM2 STAM	1.16e-03	9	108	2	PF00790
Domain	VHS	STAM2 STAM	1.16e-03	9	108	2	PS50179
Domain	VHS	STAM2 STAM	1.16e-03	9	108	2	SM00288
Domain	VHS_dom	STAM2 STAM	1.16e-03	9	108	2	IPR002014
Domain	MIR	ITPR1 ITPR2	1.45e-03	10	108	2	PS50919
Domain	MIR	ITPR1 ITPR2	1.45e-03	10	108	2	PF02815
Domain	MIR	ITPR1 ITPR2	1.45e-03	10	108	2	SM00472
Domain	ITAM_1	STAM2 STAM	1.45e-03	10	108	2	PS51055
Domain	MIR_motif	ITPR1 ITPR2	1.45e-03	10	108	2	IPR016093
Domain	Phos_immunorcpt_sig_ITAM	STAM2 STAM	1.45e-03	10	108	2	IPR003110
Domain	Methyl_CpG_DNA-bd	MBD1 SETDB1	1.76e-03	11	108	2	IPR001739
Domain	MBD	MBD1 SETDB1	1.76e-03	11	108	2	PF01429
Domain	DNA-bd_dom	MBD1 SETDB1	1.76e-03	11	108	2	IPR016177
Domain	MBD	MBD1 SETDB1	1.76e-03	11	108	2	SM00391
Domain	MBD	MBD1 SETDB1	1.76e-03	11	108	2	PS50982
Domain	GrpE_coiled_coil	GRPEL2 DNAH8	2.11e-03	12	108	2	IPR013805
Domain	UIM	STAM2 STAM	4.77e-03	18	108	2	PF02809
Domain	KRAB	ZNF584 ZFP30 ZNF275 ZNF490 ZSCAN20 ZNF780A ZNF81	5.63e-03	369	108	7	SM00349
Domain	KRAB	ZNF584 ZFP30 ZNF275 ZNF490 ZSCAN20 ZNF780A ZNF81	5.71e-03	370	108	7	IPR001909
Domain	Apc4_WD40_dom	EML6 WDR3	5.88e-03	20	108	2	IPR024977
Domain	ANAPC4_WD40	EML6 WDR3	5.88e-03	20	108	2	PF12894
Domain	UIM	STAM2 STAM	6.48e-03	21	108	2	SM00726
Pathway	REACTOME_SENSORY_PERCEPTION_OF_SALTY_TASTE	CALHM1 CALHM3 SCNN1G	2.98e-06	6	76	3	M42526
Pathway	KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING	RPS6KA1 MAPK1 MAPK3	2.98e-06	6	76	3	M47936
Pathway	SIG_BCR_SIGNALING_PATHWAY	ITPR1 ITPR2 MAPK1 MAPK3 VAV1	4.60e-06	46	76	5	M8626
Pathway	REACTOME_RSK_ACTIVATION	RPS6KA1 MAPK1 MAPK3	5.19e-06	7	76	3	M27369
Pathway	SA_B_CELL_RECEPTOR_COMPLEXES	RPS6KA1 MAPK1 MAPK3 VAV1	7.64e-06	24	76	4	M17200
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	ARPC1A ARPC1B ITPR1 ITPR2 MAPK1 MAPK3 VAV1	1.16e-05	143	76	7	M27107
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES	ARPC1A ARPC1B MAPK1 MAPK3	3.20e-05	34	76	4	MM15265
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4	REST GEM MAPK1 MAPK3	3.20e-05	34	76	4	M46422
Pathway	KEGG_LONG_TERM_POTENTIATION	RPS6KA1 ITPR1 ITPR2 MAPK1 MAPK3	3.67e-05	70	76	5	M3115
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES	ARPC1A ARPC1B MAPK1 MAPK3	4.03e-05	36	76	4	M27549
Pathway	SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES	RPS6KA1 ITPR1 ITPR2 VAV1	4.03e-05	36	76	4	M1315
Pathway	BIOCARTA_ERK5_PATHWAY	RPS6KA1 MAPK1 MAPK3	5.25e-05	14	76	3	MM1481
Pathway	BIOCARTA_ERK5_PATHWAY	RPS6KA1 MAPK1 MAPK3	5.25e-05	14	76	3	M16811
Pathway	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK	RPS6KA1 MAPK1 MAPK3	8.02e-05	16	76	3	MM15477
Pathway	WP_IL7_SIGNALING_PATHWAY	STAM2 STAM MAPK1 MAPK3	8.21e-05	43	76	4	MM15864
Pathway	WP_IL11_SIGNALING	RPS6KA1 PTPA MAPK1 MAPK3	8.99e-05	44	76	4	M39716
Pathway	WP_IL2_SIGNALING_PATHWAY	STAM2 STAM MAPK1 MAPK3 VAV1	1.04e-04	87	76	5	MM15915
Pathway	WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT	ITPR1 MAPK1 MAPK3	1.16e-04	18	76	3	M39808
Pathway	REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK	RPS6KA1 MAPK1 MAPK3	1.16e-04	18	76	3	M657
Pathway	BIOCARTA_MPR_PATHWAY	RPS6KA1 MAPK1 MAPK3	1.16e-04	18	76	3	MM1407
Pathway	REACTOME_SIGNAL_TRANSDUCTION_BY_L1	ITGA9 MAPK1 MAPK3	1.37e-04	19	76	3	MM15113
Pathway	KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY	ITPR1 ITPR2 VAV1	1.37e-04	19	76	3	M47733
Pathway	REACTOME_ERK_MAPK_TARGETS	RPS6KA1 MAPK1 MAPK3	1.37e-04	19	76	3	MM14780
Pathway	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	ARPC1A ITGA9 ARPC1B FGF2 MAPK1 MAPK3 VAV1	1.47e-04	213	76	7	M18306
Pathway	BIOCARTA_CREB_PATHWAY	RPS6KA1 MAPK1 MAPK3	1.61e-04	20	76	3	MM1520
Pathway	WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING	ITPR1 MAPK1 MAPK3	1.61e-04	20	76	3	M39485
Pathway	REACTOME_TRANSCRIPTIONAL_AND_POST_TRANSLATIONAL_REGULATION_OF_MITF_M_EXPRESSION_AND_ACTIVITY	RPS6KA1 MC5R MAPK1 MAPK3	1.61e-04	51	76	4	M48267
Pathway	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	ARPC1A ARPC1B MAPK1 MAPK3 VAV1	1.66e-04	96	76	5	M16121
Pathway	REACTOME_LEISHMANIA_INFECTION	ARPC1A ARPC1B ITPR1 ITPR2 MAPK1 MAPK3 VAV1	1.75e-04	219	76	7	M29836
Pathway	BIOCARTA_MPR_PATHWAY	RPS6KA1 MAPK1 MAPK3	1.87e-04	21	76	3	M13883
Pathway	REACTOME_SIGNAL_TRANSDUCTION_BY_L1	ITGA9 MAPK1 MAPK3	1.87e-04	21	76	3	M878
Pathway	BIOCARTA_CREB_PATHWAY	RPS6KA1 MAPK1 MAPK3	2.15e-04	22	76	3	M9070
Pathway	REACTOME_ERK_MAPK_TARGETS	RPS6KA1 MAPK1 MAPK3	2.15e-04	22	76	3	M13408
Pathway	BIOCARTA_IGF1R_PATHWAY	RPS6KA1 MAPK1 MAPK3	2.15e-04	22	76	3	MM1438
Pathway	REACTOME_NPAS4_REGULATES_EXPRESSION_OF_TARGET_GENES	GEM MAPK1 MAPK3	2.15e-04	22	76	3	M46437
Pathway	PID_FGF_PATHWAY	RPS6KA1 FGF2 MAPK1 MAPK3	2.16e-04	55	76	4	M276
Pathway	PID_IL2_1PATHWAY	STAM2 STAM MAPK1 MAPK3	2.16e-04	55	76	4	M122
Pathway	BIOCARTA_IGF1R_PATHWAY	RPS6KA1 MAPK1 MAPK3	2.47e-04	23	76	3	M19613
Pathway	BIOCARTA_BAD_PATHWAY	RPS6KA1 MAPK1 MAPK3	2.81e-04	24	76	3	MM1467
Pathway	WP_KIT_RECEPTOR_SIGNALING	RPS6KA1 MAPK1 MAPK3 VAV1	2.84e-04	59	76	4	M39350
Pathway	REACTOME_INTERLEUKIN_17_SIGNALING	RPS6KA1 NOD1 MAPK1 MAPK3	2.84e-04	59	76	4	MM15128
Pathway	BIOCARTA_PELP1_PATHWAY	MAPK1 MAPK3	2.84e-04	5	76	2	MM1575
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_USP8_TO_EGFR_ERK_ACTH_SIGNALING_PATHWAY	MAPK1 MAPK3	2.84e-04	5	76	2	M49028
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_BRAF_TO_ERK_SIGNALING_PATHWAY	MAPK1 MAPK3	2.84e-04	5	76	2	M49016
Pathway	KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_ERK_SIGNALING_PATHWAY	MAPK1 MAPK3	2.84e-04	5	76	2	M49004
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY	ITPR1 ITPR2	2.84e-04	5	76	2	M49000
Pathway	WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER	MAPK1 MAPK3	2.84e-04	5	76	2	M39621
Pathway	WP_WNT_SIGNALING_PATHWAY	ARRB2 SALL1 MAPK1 MAPK3 FZD2	3.14e-04	110	76	5	MM15977
Pathway	PID_LYMPH_ANGIOGENESIS_PATHWAY	RPS6KA1 MAPK1 MAPK3	3.18e-04	25	76	3	M274
Pathway	REACTOME_TRANSCRIPTIONAL_AND_POST_TRANSLATIONAL_REGULATION_OF_MITF_M_EXPRESSION_AND_ACTIVITY	RPS6KA1 MAPK1 MAPK3	3.18e-04	25	76	3	MM17240
Pathway	BIOCARTA_BAD_PATHWAY	RPS6KA1 MAPK1 MAPK3	3.18e-04	25	76	3	M85
Pathway	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION	RPS6KA1 REST MAPK1 MAPK3	3.23e-04	61	76	4	M152
Pathway	KEGG_OOCYTE_MEIOSIS	RPS6KA1 ITPR1 ITPR2 MAPK1 MAPK3	3.56e-04	113	76	5	M16817
Pathway	PID_ALK1_PATHWAY	ARRB2 MAPK1 MAPK3	3.58e-04	26	76	3	M185
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	ARPC1A ARPC1B MAPK1 MAPK3 VAV1	3.70e-04	114	76	5	MM14814
Pathway	BIOCARTA_ERK_PATHWAY	RPS6KA1 MAPK1 MAPK3	4.01e-04	27	76	3	M287
Pathway	BIOCARTA_GH_PATHWAY	RPS6KA1 MAPK1 MAPK3	4.01e-04	27	76	3	M9043
Pathway	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION	RPS6KA1 MAPK1 MAPK3	4.01e-04	27	76	3	MM14779
Pathway	REACTOME_PARASITE_INFECTION	ARPC1A ARPC1B MAPK1 MAPK3 VAV1	4.01e-04	116	76	5	M29843
Pathway	BIOCARTA_SAM68_PATHWAY	MAPK1 MAPK3	4.24e-04	6	76	2	MM1567
Pathway	BIOCARTA_SAM68_PATHWAY	MAPK1 MAPK3	4.24e-04	6	76	2	M22052
Pathway	BIOCARTA_PELP1_PATHWAY	MAPK1 MAPK3	4.24e-04	6	76	2	M22062
Pathway	REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY	MAPK1 MAPK3	4.24e-04	6	76	2	M27559
Pathway	REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY	MAPK1 MAPK3	4.24e-04	6	76	2	MM15273
Pathway	KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY	MAPK1 MAPK3	4.24e-04	6	76	2	M47766
Pathway	KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY	ITPR1 ITPR2	4.24e-04	6	76	2	M47960
Pathway	REACTOME_SIGNALING_BY_NODAL	MAPK1 MAPK3	4.24e-04	6	76	2	MM14517
Pathway	REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING	RPS6KA1 MAPK1 MAPK3	4.48e-04	28	76	3	M837
Pathway	BIOCARTA_ERK_PATHWAY	RPS6KA1 MAPK1 MAPK3	4.48e-04	28	76	3	MM1391
Pathway	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES	RPS6KA1 MAPK1 MAPK3	4.48e-04	28	76	3	MM15132
Pathway	WP_IL5_SIGNALING_PATHWAY	RPS6KA1 MAPK1 MAPK3 VAV1	4.89e-04	68	76	4	MM15930
Pathway	REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING	FGF2 MAPK1 MAPK3	4.97e-04	29	76	3	M27528
Pathway	REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING	FGF2 MAPK1 MAPK3	4.97e-04	29	76	3	MM15253
Pathway	REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE	RPS6KA1 NOD1 MAPK1 MAPK3 LY86	5.06e-04	122	76	5	MM14640
Pathway	KEGG_LONG_TERM_DEPRESSION	ITPR1 ITPR2 MAPK1 MAPK3	5.46e-04	70	76	4	M8232
Pathway	REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES	STAM2 RPS6KA1 REST STAM ITPR1 ITPR2 FGF2 MAPK1 MAPK3 VAV1	5.47e-04	532	76	10	M27870
Pathway	REACTOME_BACTERIAL_INFECTION_PATHWAYS	STAM2 STAM MAPK1 MAPK3	5.77e-04	71	76	4	M48033
Pathway	REACTOME_INTERLEUKIN_17_SIGNALING	RPS6KA1 NOD1 MAPK1 MAPK3	5.77e-04	71	76	4	M27382
Pathway	REACTOME_IFNG_SIGNALING_ACTIVATES_MAPKS	MAPK1 MAPK3	5.92e-04	7	76	2	MM17070
Pathway	REACTOME_SIGNALING_BY_LTK_IN_CANCER	MAPK1 MAPK3	5.92e-04	7	76	2	M48255
Pathway	REACTOME_SUPPRESSION_OF_APOPTOSIS	MAPK1 MAPK3	5.92e-04	7	76	2	M29815
Pathway	REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING	FGF2 MAPK1 MAPK3	6.07e-04	31	76	3	M27529
Pathway	REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING	FGF2 MAPK1 MAPK3	6.07e-04	31	76	3	MM15254
Pathway	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES	RPS6KA1 MAPK1 MAPK3	6.07e-04	31	76	3	M15195
Pathway	WP_4P163_COPY_NUMBER_VARIATION	FGF2 MAPK1 MAPK3	6.67e-04	32	76	3	M48083
Pathway	REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS	ARRB2 MAPK1 MAPK3	6.67e-04	32	76	3	M861
Pathway	REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS	ARRB2 MAPK1 MAPK3	6.67e-04	32	76	3	MM15148
Pathway	PID_WNT_NONCANONICAL_PATHWAY	SETDB1 ARRB2 FZD2	6.67e-04	32	76	3	M23
Pathway	WP_ALZHEIMERS_DISEASE	ITPR1 ITPR2 MAPK1 MAPK3	6.75e-04	74	76	4	MM15962
Pathway	REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING	FGF2 MAPK1 MAPK3	7.31e-04	33	76	3	M27526
Pathway	REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING	FGF2 MAPK1 MAPK3	7.31e-04	33	76	3	MM15252
Pathway	WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION	ITPR1 MAPK1 MAPK3	7.31e-04	33	76	3	M39745
Pathway	BIOCARTA_GH_PATHWAY	RPS6KA1 MAPK1 MAPK3	7.31e-04	33	76	3	MM1404
Pathway	BIOCARTA_STAT3_PATHWAY	MAPK1 MAPK3	7.86e-04	8	76	2	MM1576
Pathway	BIOCARTA_STAT3_PATHWAY	MAPK1 MAPK3	7.86e-04	8	76	2	M22063
Pathway	REACTOME_IFNG_SIGNALING_ACTIVATES_MAPKS	MAPK1 MAPK3	7.86e-04	8	76	2	M48010
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY	MAPK1 MAPK3	7.86e-04	8	76	2	M47642
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY	MAPK1 MAPK3	7.86e-04	8	76	2	M47643
Pathway	REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING	FGF2 MAPK1 MAPK3	7.99e-04	34	76	3	M27527
Pathway	PID_MAPK_TRK_PATHWAY	RPS6KA1 MAPK1 MAPK3	7.99e-04	34	76	3	M270
Pubmed	Homocysteine inhibits proliferation of neuronal precursors in the mouse adult brain by impairing the basic fibroblast growth factor signaling cascade and reducing extracellular regulated kinase 1/2-dependent cyclin E expression.	FGF2 MAPK1 MAPK3	2.99e-08	3	109	3	18703672
Pubmed	Reactive oxygen species regulate prosurvival ERK1/2 signaling and bFGF expression in gliosis within the retina.	FGF2 MAPK1 MAPK3	2.99e-08	3	109	3	22956616
Pubmed	Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.	ARRB2 MAPK1 MAPK3	2.99e-08	3	109	3	26324936
Pubmed	Phosphorylation of β-arrestin2 at Thr383 by MEK underlies β-arrestin-dependent activation of Erk1/2 by GPCRs.	ARRB2 MAPK1 MAPK3	2.99e-08	3	109	3	28169830
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZNF536 ZNF462 SETDB1 ARRB2 SALL1 ZBTB10 ANKRD17 ANKRD28 ANKRD52 ZMYM3 TANGO6	8.86e-08	418	109	11	34709266
Pubmed	Evidence That ITPR2-Mediated Intracellular Calcium Release in Oligodendrocytes Regulates the Development of Carbonic Anhydrase II + Type I/II Oligodendrocytes and the Sizes of Myelin Fibers.	ITPR1 ITPR2 MAPK1 MAPK3	8.92e-08	14	109	4	34630045
Pubmed	Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription.	ARRB2 MAPK1 MAPK3	1.20e-07	4	109	3	18006496
Pubmed	Phosphorylation of KIBRA by the extracellular signal-regulated kinase (ERK)-ribosomal S6 kinase (RSK) cascade modulates cell proliferation and migration.	RPS6KA1 MAPK1 MAPK3	1.20e-07	4	109	3	24269383
Pubmed	Basic fibroblast growth factor antagonizes activin A-mediated growth inhibition and hemoglobin synthesis in K562 cells by activating ERK1/2 and deactivating p38 MAP kinase.	FGF2 MAPK1 MAPK3	1.20e-07	4	109	3	15249224
Pubmed	Essential role for ERK2 mitogen-activated protein kinase in placental development.	RPS6KA1 MAPK1 MAPK3	1.20e-07	4	109	3	14622137
Pubmed	SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling.	FGF2 MAPK1 MAPK3	1.20e-07	4	109	3	20335309
Pubmed	Regulation of alveolar epithelial Na+ channels by ERK1/2 in chlorine-breathing mice.	SCNN1G MAPK1 MAPK3	1.20e-07	4	109	3	21997487
Pubmed	Canonical FGFs Prevent Osteogenic Lineage Commitment and Differentiation of Human Bone Marrow Stromal Cells Via ERK1/2 Signaling.	FGF2 MAPK1 MAPK3	1.20e-07	4	109	3	27305863
Pubmed	Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.	ARRB2 MAPK1 MAPK3	1.20e-07	4	109	3	15355986
Pubmed	Two distinct mechanisms mediate acute mu-opioid receptor desensitization in native neurons.	ARRB2 MAPK1 MAPK3	1.20e-07	4	109	3	19279269
Pubmed	Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by beta-arrestins 1 and 2.	ARRB2 MAPK1 MAPK3	1.20e-07	4	109	3	14711824
Pubmed	ERK1/2-p90RSK-mediated phosphorylation of Na+/H+ exchanger isoform 1. A role in ischemic neuronal death.	RPS6KA1 MAPK1 MAPK3	1.20e-07	4	109	3	17664275
Pubmed	Regulation of protein kinase A activity by p90 ribosomal S6 kinase 1.	RPS6KA1 MAPK1 MAPK3	1.20e-07	4	109	3	19808666
Pubmed	The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation.	ARRB2 MAPK1 MAPK3	2.98e-07	5	109	3	22174878
Pubmed	Differential effects of beta-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2.	ARRB2 MAPK1 MAPK3	2.98e-07	5	109	3	17442737
Pubmed	Kynurenine inhibits fibroblast growth factor 2-mediated expression of crystallins and MIP26 in lens epithelial cells.	FGF2 MAPK1 MAPK3	2.98e-07	5	109	3	20478381
Pubmed	The Vascular Endothelial Growth Factor-A phosphorylates Murine Double Minute-2 on its Serine 166 via the Extracellular Signal-Regulated Kinase 1/2 and p90 Ribosomal S6 Kinase in primary human endothelial cells.	RPS6KA1 MAPK1 MAPK3	2.98e-07	5	109	3	27591897
Pubmed	Role for engagement of β-arrestin2 by the transactivated EGFR in agonist-specific regulation of δ receptor activation of ERK1/2.	ARRB2 MAPK1 MAPK3	2.98e-07	5	109	3	26211551
Pubmed	Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo.	RPS6KA1 MAPK1 MAPK3	2.98e-07	5	109	3	9915826
Pubmed	Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways.	F10 MAPK1 MAPK3	2.98e-07	5	109	3	20451919
Pubmed	Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.	RPS6KA1 MAPK1 MAPK3	5.95e-07	6	109	3	12832467
Pubmed	EGFR and PKC are involved in the activation of ERK1/2 and p90 RSK and the subsequent proliferation of SNU-407 colon cancer cells by muscarinic acetylcholine receptors.	RPS6KA1 MAPK1 MAPK3	5.95e-07	6	109	3	22865467
Pubmed	FGF and ERK signaling coordinately regulate mineralization-related genes and play essential roles in osteocyte differentiation.	FGF2 MAPK1 MAPK3	5.95e-07	6	109	3	21678127
Pubmed	Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways.	FGF2 MAPK1 MAPK3	5.95e-07	6	109	3	18788932
Pubmed	The MAP kinase ERK5 binds to and phosphorylates p90 RSK.	RPS6KA1 MAPK1 MAPK3	5.95e-07	6	109	3	16626623
Pubmed	Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinases.	RPS6KA1 MAPK1 MAPK3	5.95e-07	6	109	3	8939914
Pubmed	GPR54 regulates ERK1/2 activity and hypothalamic gene expression in a Gα(q/11) and β-arrestin-dependent manner.	ARRB2 MAPK1 MAPK3	1.04e-06	7	109	3	20886089
Pubmed	Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs.	RPS6KA1 MAPK1 MAPK3	1.04e-06	7	109	3	12594221
Pubmed	2-O Heparan Sulfate Sulfation by Hs2st Is Required for Erk/Mapk Signalling Activation at the Mid-Gestational Mouse Telencephalic Midline.	FGF2 MAPK1 MAPK3	1.04e-06	7	109	3	26075383
Pubmed	The basic domain of HIV-tat transactivating protein is essential for its targeting to lipid rafts and regulating fibroblast growth factor-2 signaling in podocytes isolated from children with HIV-1-associated nephropathy.	FGF2 MAPK1 MAPK3	1.04e-06	7	109	3	24578133
Pubmed	Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma.	FGF2 MAPK1 MAPK3	1.04e-06	7	109	3	21292498
Pubmed	Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.	RPS6KA1 MAPK1 MAPK3	1.04e-06	7	109	3	15342917
Pubmed	The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.	ARRB2 MAPK1 MAPK3	1.66e-06	8	109	3	12473660
Pubmed	Protein phosphatase 6 regulatory subunits composed of ankyrin repeat domains.	ANKRD44 ANKRD28 ANKRD52	1.66e-06	8	109	3	18186651
Pubmed	B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK.	PTPA MAPK1 MAPK3	2.48e-06	9	109	3	16456541
Pubmed	Protein phosphatase 6 regulates mitotic spindle formation by controlling the T-loop phosphorylation state of Aurora A bound to its activator TPX2.	ANKRD44 ANKRD28 ANKRD52	2.48e-06	9	109	3	21187329
Pubmed	Regulation of c-Maf and αA-Crystallin in Ocular Lens by Fibroblast Growth Factor Signaling.	FGF2 MAPK1 MAPK3	3.54e-06	10	109	3	26719333
Pubmed	Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms.	ARRB2 MAPK1 MAPK3	3.54e-06	10	109	3	23242524
Pubmed	Ras subcellular localization defines extracellular signal-regulated kinase 1 and 2 substrate specificity through distinct utilization of scaffold proteins.	RPS6KA1 MAPK1 MAPK3	3.54e-06	10	109	3	19114553
Pubmed	Characterization of nuclear factors modulating the apolipoprotein D promoter during growth arrest: implication of PARP-1, APEX-1 and ERK1/2 catalytic activities.	IFI16 MAPK1 MAPK3	4.85e-06	11	109	3	20493910
Pubmed	Rab40c regulates focal adhesions and PP6 activity by controlling ANKRD28 ubiquitylation.	ANKRD44 ANKRD28 ANKRD52	6.45e-06	12	109	3	35512830
Pubmed	FGF signaling is required for anterior but not posterior specification of the murine liver bud.	FGF2 MAPK1 MAPK3	6.45e-06	12	109	3	25302779
Pubmed	HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway.	FGF2 MAPK1 MAPK3	6.45e-06	12	109	3	16436505
Pubmed	Inactivation of fibroblast growth factor binding protein 3 causes anxiety-related behaviors.	FGF2 MAPK1 MAPK3	8.37e-06	13	109	3	20851768
Pubmed	Expression and activation of mitogen-activated protein kinase in the human endometrium during the menstrual cycle.	MAPK1 MAPK3	9.73e-06	2	109	2	16796978
Pubmed	Mitogen-activated protein kinase phosphorylates and regulates the HIV-1 Vif protein.	MAPK1 MAPK3	9.73e-06	2	109	2	9792705
Pubmed	Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2.	MAPK1 MAPK3	9.73e-06	2	109	2	27564099
Pubmed	A role for ERK2 in reconsolidation of fear memories in mice.	MAPK1 MAPK3	9.73e-06	2	109	2	16504549
Pubmed	MEK1-ERK1/2 signaling regulates the cardiomyocyte non-sarcomeric actin cytoskeletal network.	MAPK1 MAPK3	9.73e-06	2	109	2	37999644
Pubmed	Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin.	MAPK1 MAPK3	9.73e-06	2	109	2	18070930
Pubmed	Genistein induces G2/M cell cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231 breast cancer cells.	MAPK1 MAPK3	9.73e-06	2	109	2	18224451
Pubmed	Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.	MAPK1 MAPK3	9.73e-06	2	109	2	23993963
Pubmed	Mechanical stress promotes angiogenesis through fibroblast exosomes.	MAPK1 MAPK3	9.73e-06	2	109	2	32962863
Pubmed	Cutting edge: Extracellular signal-related kinase is not required for negative selection of developing T cells.	MAPK1 MAPK3	9.73e-06	2	109	2	19801509
Pubmed	Protein-peptide complex crystallization: a case study on the ERK2 mitogen-activated protein kinase.	RPS6KA1 MAPK1	9.73e-06	2	109	2	23519423
Pubmed	The ERK phosphorylation levels in the amygdala predict anxiety symptoms in humans and MEK/ERK inhibition dissociates innate and learned defensive behaviors in rats.	MAPK1 MAPK3	9.73e-06	2	109	2	34316004
Pubmed	Inhibition of the ERK pathway prevents HIVgp120-induced REM sleep increase.	MAPK1 MAPK3	9.73e-06	2	109	2	11532249
Pubmed	A novel protein encoded by circUBE4B promotes progression of esophageal squamous cell carcinoma by augmenting MAPK/ERK signaling.	UBE4B MAPK1	9.73e-06	2	109	2	37264022
Pubmed	Lipopolysaccharide can modify differentiation and immunomodulatory potential of periodontal ligament stem cells via ERK1,2 signaling.	MAPK1 MAPK3	9.73e-06	2	109	2	28295277
Pubmed	ERK1/2 controls Na,K-ATPase activity and transepithelial sodium transport in the principal cell of the cortical collecting duct of the mouse kidney.	MAPK1 MAPK3	9.73e-06	2	109	2	15456767
Pubmed	Regulation of insulin gene transcription by ERK1 and ERK2 in pancreatic beta cells.	MAPK1 MAPK3	9.73e-06	2	109	2	12810726
Pubmed	Identification of a JAK2-independent pathway regulating growth hormone (GH)-stimulated p44/42 mitogen-activated protein kinase activity. GH activation of Ral and phospholipase D is Src-dependent.	MAPK1 MAPK3	9.73e-06	2	109	2	12218045
Pubmed	Long non-coding RNA Gm2199 rescues liver injury and promotes hepatocyte proliferation through the upregulation of ERK1/2.	MAPK1 MAPK3	9.73e-06	2	109	2	29789577
Pubmed	Bradykinin promotes neuron-generating division of neural progenitor cells through ERK activation.	MAPK1 MAPK3	9.73e-06	2	109	2	27528403
Pubmed	Activation of spinal extracellular signal-regulated kinases (ERK) 1/2 is associated with the development of visceral hyperalgesia of the bladder.	MAPK1 MAPK3	9.73e-06	2	109	2	21705143
Pubmed	ERK1-deficient mice show normal T cell effector function and are highly susceptible to experimental autoimmune encephalomyelitis.	MAPK1 MAPK3	9.73e-06	2	109	2	16081808
Pubmed	Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor.	MAPK1 MAPK3	9.73e-06	2	109	2	15143154
Pubmed	Ajoene-induced cell death in human promyeloleukemic cells does not require JNK but is amplified by the inhibition of ERK.	MAPK1 MAPK3	9.73e-06	2	109	2	12555071
Pubmed	ERK1/2 is related to oestrogen receptor and predicts outcome in hormone-treated breast cancer.	MAPK1 MAPK3	9.73e-06	2	109	2	25085753
Pubmed	ERK1 and ERK2 kinases activate hydroxyurea-induced S-phase checkpoint in MCF7 cells by mediating ATR activation.	MAPK1 MAPK3	9.73e-06	2	109	2	20840867
Pubmed	ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.	MAPK1 MAPK3	9.73e-06	2	109	2	19286961
Pubmed	Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling.	MAPK1 MAPK3	9.73e-06	2	109	2	19147767
Pubmed	Posttranslational regulation of CALHM1/3 channel: N-linked glycosylation and S-palmitoylation.	CALHM1 CALHM3	9.73e-06	2	109	2	33788965
Pubmed	Anaplasma phagocytophilum AptA modulates Erk1/2 signalling.	MAPK1 MAPK3	9.73e-06	2	109	2	20716207
Pubmed	Leukaemia inhibitory factor mediated proliferation of HTR-8/SVneo trophoblast cells is dependent on activation of extracellular signal-regulated kinase 1/2.	MAPK1 MAPK3	9.73e-06	2	109	2	21635820
Pubmed	Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo.	MAPK1 MAPK3	9.73e-06	2	109	2	17709754
Pubmed	Cholesterol affects gene expression of the Jun family in colon carcinoma cells using different signaling pathways.	MAPK1 MAPK3	9.73e-06	2	109	2	23643895
Pubmed	A cellular threshold for active ERK1/2 levels determines Raf/MEK/ERK-mediated growth arrest versus death responses.	MAPK1 MAPK3	9.73e-06	2	109	2	28986121
Pubmed	Calcitonin targets extracellular signal-regulated kinase signaling pathway in human cancers.	MAPK1 MAPK3	9.73e-06	2	109	2	18055485
Pubmed	Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer.	MAPK1 MAPK3	9.73e-06	2	109	2	32444778
Pubmed	Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells.	MAPK1 MAPK3	9.73e-06	2	109	2	15322023
Pubmed	MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo.	MAPK1 MAPK3	9.73e-06	2	109	2	15096454
Pubmed	Both ERK1 and ERK2 are required for enterovirus 71 (EV71) efficient replication.	MAPK1 MAPK3	9.73e-06	2	109	2	25803100
Pubmed	Phosphate-induced apoptosis of hypertrophic chondrocytes is associated with a decrease in mitochondrial membrane potential and is dependent upon Erk1/2 phosphorylation.	MAPK1 MAPK3	9.73e-06	2	109	2	20404333
Pubmed	Desialylation of glycoconjugates on the surface of monocytes activates the extracellular signal-related kinases ERK 1/2 and results in enhanced production of specific cytokines.	MAPK1 MAPK3	9.73e-06	2	109	2	14634064
Pubmed	Deletion of ERK1 and ERK2 in the CNS causes cortical abnormalities and neonatal lethality: Erk1 deficiency enhances the impairment of neurogenesis in Erk2-deficient mice.	MAPK1 MAPK3	9.73e-06	2	109	2	21248139
Pubmed	FasL expression in cardiomyocytes activates the ERK1/2 pathway, leading to dilated cardiomyopathy and advanced heart failure.	MAPK1 MAPK3	9.73e-06	2	109	2	26566650
Pubmed	[Effect of ERK1/2 signal pathway on the proliferation of lung fibroblast activated by SiO₂].	MAPK1 MAPK3	9.73e-06	2	109	2	21126445
Pubmed	Irradiation-induced G2/M checkpoint response requires ERK1/2 activation.	MAPK1 MAPK3	9.73e-06	2	109	2	17297454
Pubmed	Stimulus-coupled spatial restriction of extracellular signal-regulated kinase 1/2 activity contributes to the specificity of signal-response pathways.	MAPK1 MAPK3	9.73e-06	2	109	2	15542825
Pubmed	Phorbol ester phorbol-12-myristate-13-acetate promotes anchorage-independent growth and survival of melanomas through MEK-independent activation of ERK1/2.	MAPK1 MAPK3	9.73e-06	2	109	2	15721302
Pubmed	Rapamycin inhibits Erk1/2-mediated neuronal apoptosis caused by cadmium.	MAPK1 MAPK3	9.73e-06	2	109	2	26046303
Pubmed	Vasoconstrictor effects of insulin in skeletal muscle arterioles are mediated by ERK1/2 activation in endothelium.	MAPK1 MAPK3	9.73e-06	2	109	2	15059773
Pubmed	Allosteric activation of the extracellular Ca2+-sensing receptor by L-amino acids enhances ERK1/2 phosphorylation.	MAPK1 MAPK3	9.73e-06	2	109	2	17212589
Pubmed	Porcine reproductive and respiratory syndrome virus replication is suppressed by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway.	MAPK1 MAPK3	9.73e-06	2	109	2	20540975
Interaction	UBE4B interactions	UBE4B AMZ1 STAM ITPR1 PTPA MAPK1 MAPK3	7.16e-06	140	102	7	int:UBE4B
Interaction	TEX19 interactions	ZBTB2 ZNF490 SALL1 ZNF648 ZBTB10	7.82e-06	54	102	5	int:TEX19
Interaction	CBX5 interactions	STAM2 ZBTB2 ZNF584 MBD1 ZNF280C REST IFI16 ZNF462 SETDB1 ZMYM3	1.32e-05	356	102	10	int:CBX5
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF536 ZBTB2 ZNF584 ZFP30 ZNF275 ZNF692 ZNF490 ZNF462 ZNF800 ZSCAN20 SALL1 ZNF780A ZNF648 ZBTB10 ZNF81 ZFP62 ZNF574	4.62e-08	718	87	17	28
GeneFamily	Protein phosphatase 6 regulatory subunits	ANKRD44 ANKRD28 ANKRD52	2.13e-06	6	87	3	699
GeneFamily	Mitogen-activated protein kinases	MAPK15 MAPK1 MAPK3	2.97e-05	13	87	3	651
GeneFamily	Inositol 1,4,5-triphosphate receptors\|Protein phosphatase 1 regulatory subunits	ITPR1 ITPR2	6.85e-05	3	87	2	297
GeneFamily	ESCRT-0	STAM2 STAM	6.85e-05	3	87	2	1115
GeneFamily	Protein phosphatase 2 modulatory subunits	PTPA LCMT1	2.27e-04	5	87	2	1265
GeneFamily	Zinc fingers MYM-type	ZMYM1 ZMYM3	3.39e-04	6	87	2	86
GeneFamily	Actin related protein 2/3 complex	ARPC1A ARPC1B	8.06e-04	9	87	2	39
GeneFamily	Zinc fingers CXXC-type\|Methyl-CpG binding domain containing	MBD1 SETDB1	1.22e-03	11	87	2	1025
GeneFamily	Ankyrin repeat domain containing	ANKRD44 ANKRD17 ANKRD28 ANKFN1 ANKRD52	6.26e-03	242	87	5	403
ToppCell	facs-GAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF692 ITPR2 ANKRD44 SALL1 GIMAP8 DNAH8	4.77e-06	176	109	6	acd05ca8952710feedbfe377b1330f3c2406d044
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-B\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AMPD1 CHODL EML6 ANKRD44 DNAH8 LY86	9.09e-06	197	109	6	0f489d26e4013d1b5a90559856ed2de32a0bb772
ToppCell	severe\|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	OAS3 IFI16 ARRB2 GYG1 BRI3 GCA	9.63e-06	199	109	6	c24aacef7405700bc5d0b736a38feea12b7f17c8
ToppCell	3'-Parenchyma_lung-Immune_Myeloid\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARPC1B ARRB2 BRI3 GCA UPP1 LY86	9.63e-06	199	109	6	e29cd315662a8a33470964d102a61f5d3f6797e9
ToppCell	Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Adora2a_(Striatum,_iSPNs)--\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	CALHM3 CALHM4 ZNF648 SCNN1G	1.34e-05	59	109	4	a8c9a99501dc244471362915dd847ab2c6e164bf
ToppCell	Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Adora2a_(Striatum,_iSPNs)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	CALHM3 CALHM4 ZNF648 SCNN1G	1.34e-05	59	109	4	469e47aa60bf7072e80db15e51da4c103b2a21ff
ToppCell	Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Adora2a_(Striatum,_iSPNs)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	CALHM3 CALHM4 ZNF648 SCNN1G	1.34e-05	59	109	4	4f9f20aa4d5ad91c01ef7e9d60b59b5bade6a399
ToppCell	droplet-Bladder-nan-3m-Hematologic-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHGA10 OAS3 F10 LY86 VAV1	3.51e-05	151	109	5	a7b1a60d68f0ed17022fe4c97af64f9f08d39fa3
ToppCell	NS-critical-d_16-33-Myeloid-Monocyte-derived_Macrophage\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	OAS3 NRN1 RFPL4A ZSCAN20 SLC27A3	3.74e-05	153	109	5	859de35b24c5d7d73be1c213b90b43362ee2e0eb
ToppCell	367C-Lymphocytic-CD4_T-cell-Treg_cell_2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	AMPD1 STAM GEM METTL8 DNAH8	3.86e-05	154	109	5	9200e2f1783e54cbc5dfc3b485b57c761af74a46
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_A\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CHODL ZFP30 F10 CD160 SLC27A3	4.23e-05	157	109	5	542944030cd9b3f3559e64f9f6598694d74003c0
ToppCell	droplet-Limb_Muscle-nan-18m-Myeloid-macrophage\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OAS3 F10 ARRB2 LY86 VAV1	5.21e-05	164	109	5	8d089844896e84935eab705ebe54f125c4b6d9ca
ToppCell	droplet-Limb_Muscle-nan-18m-Myeloid\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OAS3 F10 ARRB2 LY86 VAV1	5.21e-05	164	109	5	17fb1421476ba44999b1165f2576514f74c1f882
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHGA10 EML6 ITGA9 WDR3 ZSCAN20	5.36e-05	165	109	5	1703d3eb644b3c743ad3c5532b1d29ea010c79c8
ToppCell	E18.5-Immune-Immune_Myeloid\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARPC1B F10 ARRB2 LY86 VAV1	5.36e-05	165	109	5	57de10d9237e56fafaa58995792f998fecc77e7a
ToppCell	facs-Kidney-nan-3m-Myeloid-macrophage\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS6KA1 ITGA9 ARRB2 LY86 VAV1	5.68e-05	167	109	5	991a93e1075d562b7391f0689b2f62c1351d48d1
ToppCell	facs-Kidney-nan-3m-Myeloid\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS6KA1 ITGA9 ARRB2 LY86 VAV1	5.68e-05	167	109	5	f22d1471c785b30d096ec5cdc68974e850ed7de0
ToppCell	droplet-Limb_Muscle-nan-18m-Myeloid-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OAS3 F10 ARRB2 LY86 VAV1	5.68e-05	167	109	5	7f9eedf68a800159c5642e04dd9569ae58109bd5
ToppCell	facs-Kidney-nan-3m-Myeloid-macrophage\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS6KA1 ITGA9 ARRB2 LY86 VAV1	5.68e-05	167	109	5	934905aeaafbc215ec8f6a7903498b0e258b9220
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MBD1 F10 ARRB2 ANKRD52 VAV1	5.84e-05	168	109	5	c3d2d573f21350a4a674faff30b06ff644d00ac3
ToppCell	PND03-Immune\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ARPC1B F10 ARRB2 LY86 VAV1	6.71e-05	173	109	5	8543304ae72f781da311deca05871098eabc4a19
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Endothelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF536 NRN1 SALL1 GIMAP8 DNAH8	7.08e-05	175	109	5	c36b4526970db9ccfbe2c70b00961fab9f13b133
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF536 NRN1 SALL1 GIMAP8 DNAH8	7.08e-05	175	109	5	c1e082538f31b5c98ac63f71dcca4a1211a14708
ToppCell	facs-Mammary_Gland-Mammary_Gland-3m-Endothelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF536 NRN1 SALL1 GIMAP8 DNAH8	7.08e-05	175	109	5	2f9b5bdf8a62e8e99d1c4f677a8e5525bfd3b4ce
ToppCell	facs-Thymus-Epithelium-3m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SRP54 GEM NOD1 LY86 TANGO6	7.47e-05	177	109	5	c2b8a3a149d70f77612759dea34df9e43953c566
ToppCell	facs-Thymus-Epithelium-3m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SRP54 GEM NOD1 LY86 TANGO6	7.47e-05	177	109	5	384f841aa7b2d05815af7885e481f5affc55d897
ToppCell	facs-Thymus-Epithelium-3m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SRP54 GEM NOD1 LY86 TANGO6	7.47e-05	177	109	5	0e9e44119653abfd270e602e5e477a15e774638f
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD160 ZNF462 SUSD2 UPP1 SLC27A3	7.68e-05	178	109	5	408e41c853f608965cef9111fb87fdc311cdc7a8
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	STAM GEM SUSD2 ZNF81 KLHL17	8.30e-05	181	109	5	9275531e896e118cee043ed94fd31a0070d9581c
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	STAM GEM SUSD2 ZNF81 KLHL17	8.52e-05	182	109	5	21744c9c792e57d5d41b25986f419b2358c7057b
ToppCell	droplet-Marrow-nan-18m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARPC1B ARRB2 GYG1 GCA MAPK3	9.93e-05	188	109	5	fa7a612b0a2b35de5f76a0408168dabe5db00773
ToppCell	3'-Adult-Distal_Rectal-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NRN1 IFI16 ITPR1 GIMAP8 FGF2	1.02e-04	189	109	5	0c612ff5f882f2d8ec744a347780bbbe7cc471bd
ToppCell	3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NRN1 IFI16 ITPR1 GIMAP8 FGF2	1.02e-04	189	109	5	bc8949bd4f425ed36e2c05e653c94cb1593c5bee
ToppCell	ILEUM-non-inflamed-(1)_T_cell-(1)_Tregs\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	STAM GEM ARPC1B METTL8 DNAH8	1.04e-04	190	109	5	f69a4733b5d1542ab4d0eb44856f2c5c34c18b9e
ToppCell	facs-Brain_Myeloid\|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS6KA1 ARRB2 SALL1 LY86 VAV1	1.07e-04	191	109	5	bf1135b382a3bf8cddc19538bc38361ef1fc2de1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IFI16 ARRB2 GIMAP8 LY86 VAV1	1.18e-04	195	109	5	42bfdff88da1d07828c0ad65d412fb1752f0cee4
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo\|GI_small-bowel / Manually curated celltypes from each tissue	AMZ1 STAM GEM CD160 MAPK1	1.21e-04	196	109	5	a54ec174461944229c98a0b48b4822a556191ccb
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Trm_Tgd\|GI_small-bowel / Manually curated celltypes from each tissue	AMZ1 STAM GEM CD160 MAPK1	1.21e-04	196	109	5	84cab9390794fe50203834b745722bf11c208ebd
ToppCell	facs-Brain_Myeloid-Cortex_-18m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS6KA1 ARRB2 SALL1 BRI3 VAV1	1.24e-04	197	109	5	e73ca8c8f42cbcc56eaa5fe3d69abd1ce7b7bbca
ToppCell	facs-Brain_Myeloid-Cortex_\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS6KA1 ARRB2 SALL1 BRI3 VAV1	1.24e-04	197	109	5	81379fe6bd14a1ba26f4a159497262adcb600b18
ToppCell	facs-Brain_Myeloid-Cortex_-18m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS6KA1 ARRB2 SALL1 BRI3 VAV1	1.24e-04	197	109	5	271c75f491d03bd248c7ec037ef02e39456f3ac0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IFI16 ANKRD44 ARRB2 LY86 VAV1	1.24e-04	197	109	5	d95565652ca318a2298d6918d54ba6367e9560f4
ToppCell	facs-Brain_Myeloid-Cortex_-18m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS6KA1 ARRB2 SALL1 BRI3 VAV1	1.24e-04	197	109	5	9db329c6fea532dd1afb624f4c29c92407f45568
ToppCell	facs-Brain_Myeloid-Cortex_-18m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS6KA1 ARRB2 SALL1 BRI3 VAV1	1.24e-04	197	109	5	173c0c8de4e69882a9f91189deeb4a651fefe551
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-F_2\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZNF280C STAM ARPC1B METTL8 DNAH8	1.24e-04	197	109	5	54fb7197db3c0dc87a1114e1ab1d2bfafd564b35
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IFI16 ARPC1B ARRB2 GCA LY86	1.27e-04	198	109	5	8a29a5a1c3b4dd7af97db303091c90ad379504d6
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	STAM GEM ARPC1B METTL8 DNAH8	1.27e-04	198	109	5	03423d6c614440b9c738f75ac3f5a6941719a279
ToppCell	Fetal_29-31_weeks-Immune\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ITPR2 ANKRD44 ARRB2 LY86 VAV1	1.27e-04	198	109	5	5dff131356b8c22743bd27b2b21f86ee6e4a0a0d
ToppCell	Smart-seq2-thymus_(Smart-seq2)-myeloid\|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ARPC1B ARRB2 BRI3 GCA UPP1	1.27e-04	198	109	5	2e470249edc7cf85bed550795ff84cbef22895c0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IFI16 ANKRD44 ARRB2 LY86 VAV1	1.30e-04	199	109	5	04adf46975aa4194ea40c7480f8a517def5d929c
ToppCell	3'_v3-blood-Myeloid_Monocytic\|blood / Manually curated celltypes from each tissue	ARPC1B ARRB2 BRI3 GCA LY86	1.30e-04	199	109	5	bf3a5085a5ae50f2ef745dce0a4ca8833b9438fd
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARRB2 SALL1 GIMAP8 LY86 VAV1	1.30e-04	199	109	5	744b63fba33b176ab7dde11646ccb313665505f7
ToppCell	cellseq-Immune-Immune_Myeloid\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ARPC1B ARRB2 GCA UPP1 LY86	1.30e-04	199	109	5	f151a209bfcdb3d17b6bdf995415b63c2ee07246
ToppCell	367C-Myeloid\|367C / Donor, Lineage, Cell class and subclass (all cells)	ARRB2 BRI3 GCA UPP1 LY86	1.30e-04	199	109	5	89f42cbd9231adec86e704ef460b2d8fd1afc00a
ToppCell	3'_v3-blood-Myeloid_Monocytic-Classical_monocytes\|blood / Manually curated celltypes from each tissue	ARPC1B ARRB2 BRI3 GCA LY86	1.30e-04	199	109	5	95b27f4bf1300f885b95c1a70a54252274dc8f51
ToppCell	cellseq-Immune\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ARPC1B ARRB2 GCA UPP1 LY86	1.30e-04	199	109	5	d564386a684e542b42a2f4d3b2053cef72a87700
ToppCell	5'-Parenchyma_lung-Immune_Myeloid\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARPC1B ARRB2 GCA UPP1 LY86	1.33e-04	200	109	5	37a091925b214a0befea59b711ab92809a7b93c8
ToppCell	Sepsis-ICU-SEP-Lymphocyte-T/NK-dn_T\|ICU-SEP / Disease, condition lineage and cell class	SETDB1 C2CD3 ZNF780A ANKRD28 ZNF81	1.33e-04	200	109	5	9ee3e18dc429b9c472e3e366d9bfdbb150daa369
ToppCell	Control-Control-Myeloid-cDC2\|Control / Disease, condition lineage and cell class	IFI16 GEM ARPC1B GCA LY86	1.33e-04	200	109	5	fd769cb21cac2364212524ef4786e77a4cc7faa7
ToppCell	10x3'2.3-week_14-16-Myeloid_monocytic-monocyte-CD14_monocyte\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ARPC1B ARRB2 BRI3 GCA LY86	1.33e-04	200	109	5	527b7388700096686293f3f6b112269e87908dfa
Drug	dimethyl selenone	MAPK15 FGF2 MAPK1 MAPK3	6.87e-09	6	107	4	CID000176413
Drug	3,5-diiodothyropropionic acid	FGF2 MAPK1 MAPK3	1.01e-07	3	107	3	ctd:C082182
Drug	xestospongin C	ITPR1 ITPR2 MAPK1 MAPK3	2.22e-07	12	107	4	ctd:C511704
Drug	pamoic acid	ARRB2 MAPK1 MAPK3	4.02e-07	4	107	3	ctd:C004368
Drug	JTE 907	ARRB2 MAPK1 MAPK3	4.02e-07	4	107	3	ctd:C422645
Drug	PD 166285	FGF2 MAPK1 MAPK3	4.02e-07	4	107	3	ctd:C109647
Drug	PD 198306	ARRB2 MAPK1 MAPK3	1.00e-06	5	107	3	ctd:C475178
Drug	BAY 60-6583	FGF2 MAPK1 MAPK3	1.00e-06	5	107	3	ctd:C518875
Drug	Niclosamide [50-65-7]; Up 200; 12.2uM; PC3; HT_HG-U133A	IFI16 CBS GEM ITPR2 ZBTB10 FGF2 UPP1 NR1H4	1.30e-06	168	107	8	4018_UP
Drug	Dobutamine	ARRB2 SCNN1G FGF2 MAPK1 MAPK3 NR1H4	1.83e-06	78	107	6	ctd:D004280
Drug	dipropionamide	MAPK15 MAPK1 MAPK3	2.00e-06	6	107	3	CID000138646
Drug	ethyl 8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carboxylate	FGF2 MAPK1 MAPK3	2.00e-06	6	107	3	ctd:C560274
Drug	N-(piperidin-1-yl)-1-(2,4-dichlorophenyl)-1,4-dihydro-6-methylindeno(1,2-c)pyrazole-3-carboxamide	ARRB2 MAPK1 MAPK3	2.00e-06	6	107	3	ctd:C553580
Drug	lercanidipine	MAPK1 MAPK3 NR1H4	3.48e-06	7	107	3	ctd:C060343
Drug	thunberginol B	MAPK15 MAPK1 MAPK3	5.56e-06	8	107	3	CID005473310
Drug	DEAC	RPS6KA1 ITGA9 MAPK15 MAPK1 MAPK3	6.02e-06	55	107	5	CID000007277
Drug	arabinosyladenine	AMPD1 OAS3 CBS NT5DC1 F10 ITPR1 PTPA MAPK15 SCNN1G BRI3 UPP1 MAPK1 HARS1 MAPK3	1.34e-05	762	107	14	CID000000191
Drug	GYY 4137	CBS MAPK1 MAPK3	1.62e-05	11	107	3	ctd:C529376
Drug	BI D1870	RPS6KA1 MAPK1 MAPK3	1.62e-05	11	107	3	ctd:C516541
Drug	14,15-epoxy-5,8,11-eicosatrienoic acid	FGF2 MAPK1 MAPK3	2.15e-05	12	107	3	ctd:C046782
Drug	N-acetyl glycine cysteine amide	MAPK1 MAPK3	2.19e-05	2	107	2	ctd:C510898
Drug	N-acetyl-Cys-Gly-Pro-Cys-amide	MAPK1 MAPK3	2.19e-05	2	107	2	ctd:C510899
Drug	cysteinyl-leukotriene	MAPK1 MAPK3	2.19e-05	2	107	2	ctd:C112381
Drug	NP00111	MAPK1 MAPK3	2.19e-05	2	107	2	ctd:C530042
Drug	substance P (6-11), Tyr(6)-D-Phe(7)-D-His(9)-	MAPK1 MAPK3	2.19e-05	2	107	2	ctd:C496429
Drug	7-methyljuglone	MAPK1 MAPK3	2.19e-05	2	107	2	ctd:C517013
Drug	sodium tetrasulfide	MAPK1 MAPK3	2.19e-05	2	107	2	ctd:C519323
Drug	2,2',4,4',5,5'-hexabrominated diphenyl ether	MAPK1 MAPK3	2.19e-05	2	107	2	ctd:C478854
Drug	CGP 56999A	MAPK1 MAPK3	2.19e-05	2	107	2	ctd:C102659
Drug	AG 127	MAPK1 MAPK3	2.19e-05	2	107	2	ctd:C069028
Drug	NF023	MAPK1 MAPK3	2.19e-05	2	107	2	ctd:C105374
Drug	tyrphostin 51	MAPK1 MAPK3	2.19e-05	2	107	2	ctd:C118515
Drug	L 759656	MAPK1 MAPK3	2.19e-05	2	107	2	ctd:C118949
Drug	N-(4-aminobutyl)-1-naphthalenesulfonamide	MAPK15 MAPK1 MAPK3	2.79e-05	13	107	3	CID000005679
Drug	Guanosine	UPP1 MAPK1 MAPK3	2.79e-05	13	107	3	ctd:D006151
Drug	SB202474	MAPK15 MAPK1 MAPK3	3.54e-05	14	107	3	CID000005162
Drug	2-amino-4-phosphonobutyric acid	ARRB2 MAPK1 MAPK3	3.54e-05	14	107	3	ctd:C012729
Drug	Noscapine [128-62-1]; Down 200; 9.6uM; HL60; HG-U133A	STAM2 UBE4B IFI16 NOD1 MAPK3 ZMYM3 SLC27A3	4.37e-05	199	107	7	1753_DN
Drug	Enkephalin, Ala(2)-MePhe(4)-Gly(5)-	ARRB2 MAPK1 MAPK3	4.41e-05	15	107	3	ctd:D020875
Drug	SCH772984	FGF2 MAPK1 MAPK3	4.41e-05	15	107	3	ctd:C587178
Drug	picropodophyllin	MAPK1 MAPK3 NR1H4	4.41e-05	15	107	3	ctd:C415032
Drug	sodium ferulate	MC5R MAPK15 GYG1 MAPK1 MAPK3	6.00e-05	88	107	5	CID000000709
Drug	withaferin A	MAPK15 UPP1 MAPK1 MAPK3	6.46e-05	46	107	4	CID000265237
Drug	RG-13577	FGF2 MAPK1 MAPK3	6.54e-05	17	107	3	CID003081306
Drug	PQ 401	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C569479
Drug	cassine	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C426663
Drug	manganese(III) acetate dihydrate	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C521134
Drug	Nipaam-ntbam copolymer	MAPK1 MAPK3	6.54e-05	3	107	2	CID003080965
Drug	delta(4)-tibolone	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C485706
Drug	tPA stop	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C115645
Drug	LBT 613	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C514877
Drug	AAL 881	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C514876
Drug	NGB 2904	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C116818
Drug	19-epi-okadaic acid	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C522300
Drug	alpha-methyl-4-carboxyphenylglycine	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C079694
Drug	5-chloro-2-methyl-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C534240
Drug	YM-254890	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C475455
Drug	poly(N-isopropylacrylamide-N-tert-butylacrylamide)copolymer	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C079805
Drug	capsanthin	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C006889
Drug	hispidulin	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C055957
Drug	bromoxynil octanoate	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C028382
Drug	HFMC	FGF2 MAPK1	6.54e-05	3	107	2	CID000175887
Drug	Pyridazines	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:D011724
Drug	SB 258585	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C418570
Drug	connective tissue-activating peptide	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C009862
Drug	spectaline	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C480880
Drug	p38alpha inhibitor CMPD1	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C492719
Drug	OR486	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C057726
Drug	GW2974	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C506645
Drug	kaempferol-7-methyl ether	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C541117
Drug	wogonoside	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C473995
Drug	Ginkgolides	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:D046934
Drug	ML 204	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C567966
Drug	hwanggunchungyitang	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C539018
Drug	BPC96 peptide	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C555919
Drug	N,N''-1,4-butanediylbis(N'-(3-isothiocyanatophenyl))thiourea	MAPK1 MAPK3	6.54e-05	3	107	2	ctd:C541384
Drug	SRT1720	FGF2 MAPK1 MAPK3 NR1H4	7.04e-05	47	107	4	ctd:C525422
Drug	Iloprost	FGF2 MAPK1 MAPK3	9.26e-05	19	107	3	ctd:D016285
Drug	Alprenolol	ARRB2 MAPK1 MAPK3	9.26e-05	19	107	3	ctd:D000526
Drug	fenvalerate	ITPR1 MAPK1 MAPK3 HSD17B1 NR1H4	9.54e-05	97	107	5	ctd:C017690
Drug	2,2',3,5',6-pentachlorobiphenyl	REST MAPK1 MAPK3	1.09e-04	20	107	3	ctd:C032904
Drug	SR 57746A	PTPA MAPK1 MAPK3	1.09e-04	20	107	3	CID000128918
Drug	SU 6656	RPS6KA1 MAPK1 MAPK3	1.26e-04	21	107	3	ctd:C416927
Drug	isosalipurposide	MAPK1 MAPK3	1.30e-04	4	107	2	ctd:C027321
Drug	diacetylbis(4-methylthiosemicarbazonato)copper(II)	MAPK1 MAPK3	1.30e-04	4	107	2	ctd:C570445
Drug	2-(2-oxo-2-((3,7,11-trimethyl-2,6,10-dodecatrienyl)oxy)aminoethyl)phosphonic acid, (2,2-dimethyl-1-oxopropoxy)methyl ester sodium	MAPK1 MAPK3	1.30e-04	4	107	2	ctd:C436083
Drug	2,3,4,2',3',4'-hexachlorobiphenyl	MAPK1 MAPK3	1.30e-04	4	107	2	ctd:C014218
Drug	3-(phenylsulfonyl)-4-(2-(4-(2-(3,7,11-trimethyldodeca-2,6,10-trienylthio)benzoyl)piperazin-1-yl)ethoxy)-1,2,5-oxadiazole-2-oxide	MAPK1 MAPK3	1.30e-04	4	107	2	ctd:C559860
Drug	Purvalanol	MAPK1 MAPK3	1.30e-04	4	107	2	DB02733
Drug	Dmt-NMe-Ala-Aba-Gly-NH2	MAPK1 MAPK3	1.30e-04	4	107	2	ctd:C569763
Drug	O(2)-(2,4-dinitrophenyl) 1-(4-(N,N-diethylcarboxamido)piperazin-1-yl)diazen-1-ium 1,2-diolate	MAPK1 MAPK3	1.30e-04	4	107	2	ctd:C495194
Drug	3-(4-Amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo(3,4-b)pyridine	MAPK1 MAPK3	1.30e-04	4	107	2	ctd:C423582
Drug	4,4,',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakis(benzene-1,3-disulfonate)	MAPK1 MAPK3	1.30e-04	4	107	2	ctd:C110258
Drug	phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide	MAPK1 MAPK3	1.30e-04	4	107	2	ctd:C049352
Drug	2,5,3'-trichlorobiphenyl	MAPK1 MAPK3	1.30e-04	4	107	2	ctd:C091160
Drug	bovine serum albumin-corticosterone conjugate	MAPK1 MAPK3	1.30e-04	4	107	2	ctd:C439264
Drug	corticosterone-21-hemisuccinate	MAPK1 MAPK3	1.30e-04	4	107	2	ctd:C067957
Drug	ado-trastuzumab emtansine	MAPK1 MAPK3	1.30e-04	4	107	2	ctd:C550911
Drug	neurotropin	MAPK1 MAPK3	1.30e-04	4	107	2	ctd:C010491
Drug	N-(4-chloro-2-((1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl)phenyl)-2-hydroxybenzamide	MAPK1 MAPK3	1.30e-04	4	107	2	ctd:C481448
Disease	Anoxic Encephalopathy	ITPR1 ITPR2	1.18e-05	2	102	2	C0003132
Disease	Brain Hypoxia	ITPR1 ITPR2	1.18e-05	2	102	2	C1527348
Disease	Anoxia of brain	ITPR1 ITPR2	1.18e-05	2	102	2	C0995195
Disease	Hypoxic Brain Damage	ITPR1 ITPR2	1.18e-05	2	102	2	C1140716
Disease	schizophrenia (is_marker_for)	ARPC1A ARPC1B SETDB1 MAPK3	1.64e-05	44	102	4	DOID:5419 (is_marker_for)
Disease	Astrocytosis	FGF2 MAPK1 MAPK3	2.63e-05	17	102	3	C3887640
Disease	Gliosis	FGF2 MAPK1 MAPK3	2.63e-05	17	102	3	C0017639
Disease	non-alcoholic fatty liver disease, type 2 diabetes mellitus	AMZ1 ABHD10 SLC9C2 ARPC1B DNAH8	4.10e-05	110	102	5	EFO_0003095, MONDO_0005148
Disease	CEROID LIPOFUSCINOSIS, NEURONAL, 6	MAPK1 MAPK3	1.76e-04	6	102	2	C1866282
Disease	Streptococcal pneumonia	MAPK1 MAPK3	1.76e-04	6	102	2	C0155862
Disease	endometrial adenocarcinoma (is_implicated_in)	MAPK1 MAPK3	2.46e-04	7	102	2	DOID:2870 (is_implicated_in)
Disease	ureteral obstruction (implicated_via_orthology)	MAPK1 MAPK3	4.19e-04	9	102	2	DOID:5199 (implicated_via_orthology)
Disease	lymphocyte count	UBE4B PCDHGA10 RPS6KA1 AMZ1 ARPC1A EML6 REST ITPR1 ITPR2 ZNF800 ARRB2 GIMAP8 FGF2 VAV1	5.12e-04	1464	102	14	EFO_0004587
Disease	Muscle Weakness	AMPD1 GYG1	5.23e-04	10	102	2	C0151786
Disease	hyperhomocysteinemia (implicated_via_orthology)	CBS F10	6.38e-04	11	102	2	DOID:9279 (implicated_via_orthology)
Disease	endometrial adenocarcinoma (is_marker_for)	MAPK1 MAPK3	6.38e-04	11	102	2	DOID:2870 (is_marker_for)
Disease	Cocaine-Related Disorders	FGF2 MAPK1 MAPK3 DNAH8	7.40e-04	117	102	4	C0236736
Disease	Trigeminal Neuralgia	MAPK1 MAPK3	7.64e-04	12	102	2	C0040997
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ITPR1 ITPR2	7.64e-04	12	102	2	DOID:1441 (implicated_via_orthology)
Disease	Secondary Trigeminal Neuralgia	MAPK1 MAPK3	7.64e-04	12	102	2	C0393787
Disease	Trigeminal Neuralgia, Idiopathic	MAPK1 MAPK3	7.64e-04	12	102	2	C0393786
Disease	Cocaine Abuse	FGF2 MAPK1 MAPK3 DNAH8	1.00e-03	127	102	4	C0009171
Disease	gastric ulcer (implicated_via_orthology)	MAPK1 MAPK3	1.05e-03	14	102	2	DOID:10808 (implicated_via_orthology)
Disease	polycystic kidney disease (implicated_via_orthology)	STAM2 STAM	1.05e-03	14	102	2	DOID:0080322 (implicated_via_orthology)
Disease	FEV change measurement, response to bronchodilator	MBD1 MC5R UBR3	1.08e-03	58	102	3	EFO_0005921, GO_0097366
Disease	Bipolar Disorder	ITGA9 CBS ITPR1 PTPA ARRB2 MAPK1 DNAH8	1.36e-03	477	102	7	C0005586
Disease	succinylcarnitine measurement	ZNF536 PTPA	1.38e-03	16	102	2	EFO_0020020
Disease	Cocaine Dependence	FGF2 MAPK1 MAPK3 DNAH8	1.40e-03	139	102	4	C0600427
Disease	MAJOR AFFECTIVE DISORDER 2	ITGA9 PTPA	1.56e-03	17	102	2	C1839839
Disease	Fetal Alcohol Syndrome	RPS6KA1 REST	1.56e-03	17	102	2	C0015923
Disease	Hypertrophy	MAPK1 MAPK3	1.75e-03	18	102	2	C0020564
Disease	prostate adenocarcinoma (is_implicated_in)	FGF2 MAPK1	2.16e-03	20	102	2	DOID:2526 (is_implicated_in)
Disease	Nerve Degeneration	FGF2 MAPK1 MAPK3	3.02e-03	83	102	3	C0027746
Disease	C-reactive protein measurement	ZNF536 UBE4B HYKK RPS6KA1 IFI16 NT5DC1 ITPR1 ANKRD44 SALL1 NR1H4 SLC27A3	3.03e-03	1206	102	11	EFO_0004458
Disease	Septicemia	MAPK1 MAPK3	3.11e-03	24	102	2	C0036690
Disease	Anhedonia	SETDB1 MAPK1	3.11e-03	24	102	2	C0178417
Disease	Sepsis	MAPK1 MAPK3	3.11e-03	24	102	2	C0243026
Disease	Severe Sepsis	MAPK1 MAPK3	3.11e-03	24	102	2	C1719672
Disease	Head Neoplasms	MAPK1 MAPK3	3.11e-03	24	102	2	C0018675
Disease	Upper Aerodigestive Tract Neoplasms	MAPK1 MAPK3	3.11e-03	24	102	2	C0887900
Disease	Pyemia	MAPK1 MAPK3	3.11e-03	24	102	2	C0034189
Disease	Cancer of Head	MAPK1 MAPK3	3.11e-03	24	102	2	C0751177
Disease	reticulocyte count	RPS6KA1 ZNF280C EML6 REST ARPC1B F10 ZNF800 NOD1 GIMAP8 LY86	3.34e-03	1045	102	10	EFO_0007986
Disease	Neck Neoplasms	MAPK1 MAPK3	3.37e-03	25	102	2	C0027533
Disease	Cancer of Neck	MAPK1 MAPK3	3.37e-03	25	102	2	C0746787

Protein segments in the cluster

Peptide	Gene	Start	Entry
LCRVAFCFLAVGLVD	TRBV28	6	A0A5B6
LCSCTEAFFLGLRVK	AMZ1	116	Q400G9
CRVGVLEDCFTFLGI	BRI3	81	O95415
FVVFLCKDRSGDCSP	CD160	56	O95971
LLAAGSCDFKCRIFS	ARPC1B	156	O15143
LALLDGKCFVCAFSS	CALHM3	116	Q86XJ0
GRIFFDDYVACCVKL	GCA	171	P28676
DCCRKLLSSGFDIDT	ANKRD28	386	O15084
AVTLLDGKCFLCAFC	CALHM1	116	Q8IU99
EDFEIVCKGLYRALC	AMPD1	131	P23109
ACCGGFLEVADFLIK	ANKRD17	541	O75179
LHLAVLFGFSDCCRK	ANKRD52	376	Q8NB46
LFGFSDCCRKLLSSG	ANKRD52	381	Q8NB46
CGVDFEIRAFCAKSL	ARRB2	141	P32121
LLAAGSCDFKCRVFS	ARPC1A	156	Q92747
GRACAVVFDCKFIET	GEM	206	P55040
TCFICGLERDKFDNK	ITPR2	2561	Q14571
ALTCEGCKGFFRRSI	NR1H4	151	Q96RI1
ARCTFRNFLGKEACE	CAPN15	51	O75808
RNFLGKEACEVCGFT	CAPN15	56	O75808
CDLKICDFGLARVAD	MAPK1	161	P28482
LAVKAAKGDFVCIFC	REST	1051	Q13127
FFCEILSVLKLACAD	OR2A14	176	Q96R47
FCCKGLALDLEDGNF	NT5DC1	61	Q5TFE4
EACRALVFGGCVEKS	NEIL1	16	Q96FI4
ICEAALPKFSFCGRR	LY86	101	O95711
LRLCLKRFTCEDAGA	IL17REL	141	Q6ZVW7
KTTCFICGLERDKFD	ITPR1	2616	Q14643
DANCTVKLCDFGLAR	MAPK15	146	Q8TD08
ACDLTLFDFKQGILC	MBD1	56	Q9UIS9
SKDCSGLVLLCLFFG	PCDHGA10	11	Q9Y5H3
GLCIFFVRCRNDVAI	DNAH8	16	Q96JB1
LSYKFLGERDCAAPC	FZD2	211	Q14332
CFKESDRLCLQDLLF	NOD1	241	Q9Y239
CDAVFKGFSDCLLKL	NRN1	31	Q9NPD7
TTCDLKICDFGLARI	MAPK3	176	P27361
DCCRKLLSSGFEIDT	ANKRD44	386	Q8N8A2
GLLCRFCSVVSQKDD	RFPL4A	46	A6NLU0
FFCEILAVLKLACAD	OR2A7	176	Q96R45
FVFAGLADTECCLLA	OR5C1	106	Q8NGR4
RCVEDAKIFGIQSFC	GRPEL2	96	Q8TAA5
FFCEILAVLKLACAD	OR2A4	176	O95047
CELLESDFLKCSVGF	ITGA9	696	Q13797
EKGALFLLVCSRFCQ	HYKK	301	A2RU49
FSCGFCRKEDVSGAI	GYG1	286	P46976
GVRDACCKFLLSQLD	KLHL17	176	Q6TDP4
CSGEACFLAELLEFA	C2CD3	1276	Q4AC94
YCASKFALEGLCESL	HSD17B1	156	P14061
RCLSCCEKGDTFFVL	GIMAP8	516	Q8ND71
CLELDDAIRSCKGAF	C20orf85	111	Q9H1P6
DAIRSCKGAFARELC	C20orf85	116	Q9H1P6
LKCELLAKCEFFNAG	CBS	101	P35520
ECKLACLRFFSITGR	CALHM4	96	Q5JW98
CEEGDKLQLFCFRLR	IFI16	356	Q16666
FKEIICCRGFRIACS	MC5R	306	P33032
DGRLLASKCVTDECF	FGF2	221	P09038
CALDFSADGKCLVSV	EML6	776	Q6ZMW3
TCLEGFEGKNCELFT	F10	111	P00742
CELFTRKLCSLDNGD	F10	121	P00742
LLVTCFFDGVSCDAR	SCNN1G	256	P51170
VCDPACRRFKLTDFG	SBK2	191	P0C263
GRCCAEFFELSDLLL	SALL1	46	Q9NSC2
CRFCAKVFGSDSALQ	SALL1	451	Q9NSC2
FAICGVSDSKFRTIC	HARS1	221	P12081
LYCCDFASGAVELVK	METTL8	226	Q9H825
FFCEILSVLRLACAD	OR2A1;	176	Q8NGT9
GGCDSELVIFLDCFK	OAS3	71	Q9Y6K5
GLSKCEVSCSAFIRF	FBXL21P	371	Q9UKT6
FCLCGRIYKDIFLDS	MAP3K15	361	Q6ZN16
FLRCCGCVFSERALK	RTF2	136	Q9BY42
KAFIRCVGAELGLDC	UPP1	66	Q16831
GLLCRFCSVVSQKDD	RFPL4AL1	46	F8VTS6
LGTCCLDFRDFCLEI	SUSD2	51	Q9UGT4
KTCLICADTFRAGAF	SRP54	131	P61011
VRGTCEDASLCKRFA	LCMT1	26	Q9UIC8
SFCGANEIRRVFCDI	OR5T2	206	Q8NGG2
GIRCLDDIAKGSFVC	SETDB1	816	Q15047
IEEFCKSLGHACIRF	ABHD10	96	Q9NUJ1
FTCSKIIGRRFACFA	ANKFN1	16	Q8N957
GCAFLTYCERESALK	CELF4	96	Q9BZC1
CRRVVSGQKVCFADF	CHODL	21	Q9H9P2
CLLVARACFSDLQKG	CNGA2	156	Q16280
SSFKCIELIARCDGV	TMPRSS3	81	P57727
SGRFCDVFDKALVLC	VPS11	656	Q9H270
ECKECGKAFRLFSQL	ZFP30	411	Q9Y2G7
CLECGKFFRDRSNLI	ZSCAN20	961	P17040
EKPFVCRECGRAFFS	ZNF490	331	Q9ULM2
ADLAFAVRALCCKRA	SLC27A3	31	Q5K4L6
EAAFAAFLCCLCKIG	PTPA	191	Q15257
CKACADAGLLDESFL	UBE4B	826	O95155
TCCEKFGLKRSELFE	VAV1	81	P15498
ERPFACEVCGKAFAI	ZNF574	791	Q6ZN55
QECGLAGDFFIFCLK	TANGO6	586	Q9C0B7
CGKIFHLEVCSRDFA	STAM	76	Q92783
CGKIFHLEVCSRDFA	STAM2	76	O75886
FECNECGKAFSLLTL	ZNF780A	221	O75290
CDFQGLIGETAKLCR	SAXO2	186	Q658L1
DAVAPAAGFRCTFCK	ZNF536	266	O15090
FSVDKGEFTCPLCRQ	UBR3	1351	Q6ZT12
CDECGKAFITCRTLL	ZFP62	311	Q8NB50
AALNTEKRFPCEFCG	ZNF462	2406	Q96JM2
EKGFLCAECGRAFRI	ZNF648	501	Q5T619
DTIFECKLCRSLFRG	ZNF800	66	Q2TB10
ERAKLACFDSGDTIC	SLC9C2	881	Q5TAH2
AQREFGFLCDCTVAI	ZBTB2	16	Q8N680
RGITLVCLKCDFLAD	ZNF280C	681	Q8ND82
VCLKCDFLADSSGLD	ZNF280C	686	Q8ND82
GVRSFSCDICGKLFT	ZBTB10	746	Q96DT7
DDSCINFVSLGCLFI	ZMYM1	1041	Q5SVZ6
GSDVELICRCLFFLL	WDR3	846	Q9UNX4
FACKECGDTFRLKVL	ZNF275	101	Q9NSD4
CSDCGKVFLKAFALL	ZNF584	161	Q8IVC4
LRFSGVEKSFCSEGC	ZMYM3	646	Q14202
ETVAALRFPCEFCGK	ZNF692	441	Q9BU19
CADCGRAFIQKSELI	ZNF81	556	P51508
TCACFEILGFDILLD	TTLL13	366	A6NNM8
ECLRICDFGFAKQLR	RPS6KA1	551	Q15418